National Cancer Research Month

Learn more about Charles Mullighan
Read about Charles Mullighan's
research on childhood leukemia.

May is National Cancer Research Month, and Pew's biomedical scholars and Latin American fellows are doing their part to address the disease, which affects nearly 13 million people in the United States, according to the American Cancer Society.

More than 130 Pew-supported scientists are engaged in research for preventing or treating cancer. For instance, 2011 scholar Mei Kong studies cancer cell metabolism with the long-term goal of developing therapies that would target only cancer cells. Suzana Kahn, a 2012 Latin American fellow, examines the cells initiating glioblastomas—some of the most aggressive and difficult-to-treat brain tumors.

These projects and many more provide creative insights into the basic biology of cancer and are paving the way for new approaches to combat the disease. To learn more about Pew's programs in the biomedical sciences, click here.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.